×
Stryker Inventory 2010-2024 | SYK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stryker inventory for the quarter ending September 30, 2024 was
$5.292B
, a
8.38% increase
year-over-year.
Stryker inventory for 2023 was
$4.843B
, a
21.23% increase
from 2022.
Stryker inventory for 2022 was
$3.995B
, a
20.55% increase
from 2021.
Stryker inventory for 2021 was
$3.314B
, a
5.15% decline
from 2020.
View More
Stryker Inventory 2010-2024 | SYK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stryker inventory for 2023 was
$4.843B
, a
21.23% increase
from 2022.
Stryker inventory for 2022 was
$3.995B
, a
20.55% increase
from 2021.
Stryker inventory for 2021 was
$3.314B
, a
5.15% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$202.2B
Boston Scientific (BSX)
$130.1B
Medtronic (MDT)
$112.5B
EssilorLuxottica (ESLOY)
$111.7B
Lonza Group Ag (LZAGY)
$45.4B
Haleon (HLN)
$43.5B
GE HealthCare Technologies (GEHC)
$39.3B
ResMed (RMD)
$37B
Terumo (TRUMY)
$29.6B
Koninklijke Philips (PHG)
$25B
Zimmer Biomet Holdings (ZBH)
$21.5B
Insulet (PODD)
$18.8B
Baxter (BAX)
$17.7B
Smith & Nephew SNATS (SNN)
$10.6B
Bio-Rad Laboratories (BIO)
$10.3B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$6.1B
Haemonetics (HAE)
$4.5B
TG Therapeutics (TGTX)
$4.5B
ICU Medical (ICUI)
$4.3B
Prestige Consumer Healthcare (PBH)
$4B
Perrigo (PRGO)
$3.6B
Neogen (NEOG)
$3.5B
Envista Holdings (NVST)
$3.5B
Agios Pharmaceuticals (AGIO)
$3.4B
GN Store Nord (GNNDY)
$3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B
LeMaitre Vascular (LMAT)
$2.3B